Virus News and Research

Latest Virus News and Research

Use of HIV-prevention drug grows, but lags among non-whites

Eric Russell, 24, recently joined a health support group for young Latino and black gay men, where he learned about the HIV-prevention pill known as PrEP. He resisted the medication at first, convinced he didn't need it and fearful that taking it would stigmatize him.

15 Mar 2018

Transformative new approach for viral titer determination using xCELLigence RTCA

Accurate determination of viral titers is critical to vaccine development. Historically, titers have been determined using endpoint assays which are labor-intensive, expensive, and time-consuming. This is increasingly problematic in modern production facilities where bioprocess optimization is performed using high-throughput cell culture reactors that can produce batches of virus faster than they can be analyzed.

13 Mar 2018

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.

13 Mar 2018

Study sheds new light on viral replication

Viruses are intracellular parasites that cause disease by infecting the cells in the body and, in a study published today in Nature Microbiology, researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine showed how a common virus hijacks a host cell's protein to help assemble new viruses before they are released.

13 Mar 2018

Socioeconomic inequalities may affect outcomes for patients with anal cancer

In a study of patients with anal cancer, living in low median household income areas was linked with an increased risk of early death. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that socioeconomic inequalities may affect cancer outcomes, especially for highly treatable and curable tumors such as anal cancer.

12 Mar 2018

Poorer socioeconomic status linked to lower survival from anal cancer

If you are from a lower income area, your chances of surviving anal cancer are significantly reduced, according to a new study led by investigators at NYU Langone Health's Perlmutter Cancer Center, and publishing online March 12, 2018 in Cancer.

12 Mar 2018

Mystery 'disease X' warnings from WHO

The World Health Organization (WHO) has warned about a mysterious disease X that is caused by a virus and can cause a worldwide pandemic in the near future. WHO has come up with a list of diseases that can cause an outbreak or epidemic among the general population, mainly because of the lack of resources for fighting them.

12 Mar 2018

Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer

Pancreatic cancer is one of the less common but deadliest cancers. Modified oncolytic adenoviruses represent an alternative to chemotherapy and targeted therapies, which have a high mortality rate.

9 Mar 2018

Discovery may lead to effective research and better treatments for Ebola, other viral diseases

University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.

8 Mar 2018

Study reveals new strategy to prevent mother-to-child transmission of hepatitis B virus

A clinical study coordinated by the French National Research Institute for Sustainable Development and Chiang Mai University with their Thai, American, and French partners, strengthens the case for a new strategy to prevent mother-to-child transmission of the hepatitis B virus.

8 Mar 2018

Researchers identify new mechanism to disrupt HIV latency

HIV, the virus that causes AIDS, has a secret life. Though anti-retroviral therapy can reduce its numbers, the virus can hide and avoid both treatments and the body's immune response.

8 Mar 2018

Innovative program seeks to eliminate HCV in Iceland

A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland.

7 Mar 2018

Scientists examine viability of using new microwave system to treat HPV

University of Glasgow are leading new tests into the viability of using an innovative, new microwave system to treat human papillomavirus (HPV).

7 Mar 2018

FDA approves new antiretroviral medication for patients with multidrug-resistant HIV

Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).

6 Mar 2018

Innovative antibody delivery method could offer effective way to combat Ebola infection

More than 11,000 people died during the Ebola outbreak in West Africa from 2013-16, demonstrating both the deadly nature of the virus and the limitations of the medication used to fight it.

6 Mar 2018

Johns Hopkins doctors successfully transplant hepatitis C-infected kidneys into virus-free patients

In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of these transplants could mean more organs being available for the nearly 100,000 people in the U.S. currently waiting for a kidney transplant.

6 Mar 2018

Study assesses healthcare workers' exposures to airborne influenza virus

In United States, more than 18 million workers are employed in healthcare sector. Healthcare workers providing direct patient care services face a wide range of hazards including exposures to infectious diseases.

5 Mar 2018

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Nigeria has been affected with an outbreak of the deadly Lassa fever since the start of this year. This disease typically has a high rate of fatality, no known cure and no vaccines have been developed against it yet. This is an unprecedented outbreak of this disease that is spreading faster than before. It is infecting more individuals than health workers can handle with their limited resources, say official sources.

5 Mar 2018

Young men recovering from flu have increased risk of developing Guillain-Barré syndrome

This year's flu season has been one of the worst in recent memory causing thousands of people to be hospitalized. The virus can be particularly dangerous for young men who can experience nerve damage caused by the body's response to the flu.

2 Mar 2018

Virus-like particle could translate into new vaccine for cancer treatment

Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.

2 Mar 2018

Virus News and Research

Latest Virus News and Research

Use of HIV-prevention drug grows, but lags among non-whites

Transformative new approach for viral titer determination using xCELLigence RTCA

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

Study sheds new light on viral replication

Socioeconomic inequalities may affect outcomes for patients with anal cancer

Poorer socioeconomic status linked to lower survival from anal cancer

Mystery 'disease X' warnings from WHO

Modifying Oncolytic Adenoviruses to Target Pancreatic Cancer

Discovery may lead to effective research and better treatments for Ebola, other viral diseases

Study reveals new strategy to prevent mother-to-child transmission of hepatitis B virus

Researchers identify new mechanism to disrupt HIV latency

Innovative program seeks to eliminate HCV in Iceland

Scientists examine viability of using new microwave system to treat HPV

FDA approves new antiretroviral medication for patients with multidrug-resistant HIV

Innovative antibody delivery method could offer effective way to combat Ebola infection

Johns Hopkins doctors successfully transplant hepatitis C-infected kidneys into virus-free patients

Study assesses healthcare workers' exposures to airborne influenza virus

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Young men recovering from flu have increased risk of developing Guillain-Barré syndrome

Virus-like particle could translate into new vaccine for cancer treatment

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in